A recurrent inflammatory myofibroblastic tumor patient with two novel ALK fusions: a case report

BACKGROUND: Inflammatory myofibroblastic tumor (IMT) is a rare disease that mainly involves the lung and the abdomen. The gold standard of the IMT treatment is radical surgery, while chemotherapy and radiotherapy are represented usually for unresectable lesions. Anaplastic lymphoma kinase (ALK) rear...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiumei, Li, Ling, Zhang, Yaxuan, Meng, Fanfan, Xie, Hongmei, Duan, Ruiqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552075/
https://www.ncbi.nlm.nih.gov/pubmed/36237256
http://dx.doi.org/10.21037/tcr-22-368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552075/
https://www.ncbi.nlm.nih.gov/pubmed/36237256
http://dx.doi.org/10.21037/tcr-22-368

Ejemplares similares